John P. Kenny - Nov 15, 2021 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC (VIVO)

Role
Chief Executive Officer, Director
Signature
/s/ Bryan T. Baldasare as Attorney-in-fact for John P. Kenny
Stock symbol
VIVO
Transactions as of
Nov 15, 2021
Transactions value $
$0
Form type
4
Date filed
11/16/2021, 02:56 PM
Previous filing
Nov 8, 2021
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIVO Common Stock Other -156K -58.65% 110K Nov 15, 2021 Direct F1
transaction VIVO Common Stock Award +156K +141.86% 265K Nov 15, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.
F2 Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 99,505 on October 1, 2022; and (ii) 56,006 on November 15, 2023.